Social media platforms provide the opportunity for virtual dialogue between patients and caregivers

ESMO would like to thank the National Oncology Institute with its office at the National Cancer Institute in Bratislava for providing translation

Building evidence for genomic sequencing

It is the first systemic therapy approved for patients with this tumour

An in-depth re-analysis of recommendations beyond the FDA-approved indications

EU regulatory initiative aims to make a clearer distinction between liposomal and non-liposomal formulations of the same active substance